Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism

Thrombosis Research

Volumn 125, Issue 3, 2010, Pages

  Becattini, Cecilia ^a   Agnelli, Giancarlo ^a   Salvi, Aldo ^b   Grifoni, Stefano ^c   Pancaldi, Leonardo Goffredo ^d   Enea, Iolanda ^e   Balsemin, Franco ^f   Campanini, Mauro ^g   Ghirarduzzi, Angelo ^h   Casazza, Franco ⁱ  

^a UNIVERSITY OF PERUGIA   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d Ospedale di Bentivoglio   (Italy)

^e S Anna and S Sebastiano Hospital   (Italy)

^f UNIVERSITY OF TRIESTE   (Italy)

^g MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^h S MARIA NUOVA HOSPITAL   (Italy)

ⁱ SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Pulmonary embolism; Pulmonary hypertension; Tenecteplase; Thrombolysis; Venous thromboembolism

Indexed keywords

HEPARIN; PLACEBO; TENECTEPLASE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHOCARDIOGRAPHY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HEMATOCHEZIA; HEMATOMA; HEMATURIA; HEMODYNAMICS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

AGED; ANTICOAGULANTS; DOSAGE FORMS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PILOT PROJECTS; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 76949090384     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.09.017     Document Type: Article

References (21)

1. Kasper W., Konstantinides S., Geibel A., Tiede N., Krause T., and Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 77 (1997) 346-349
2. Goldhaber S.Z., Visani L., and De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry. Lancet 353 (1999) 1386-1389
3. Grifoni S., Olivotto I., Cecchini P., Pieralli F., Camaiti A., Santoro G., et al. Short term clinical outcome of patients with pulmonary embolism, normal blood pressare and echocardiographycal right ventricular dysfunction. Circulation 101 (2000) 2817-2822
4. Kucher N., Rossi E., De Rosa M., and Goldhaber S.Z. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 165 (2005) 1777-1781
5. Kearon C., Kahn S.R., Agnelli G., Goldhaber S., Raskob G.E., Camerota A.J., et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. [8th Edition]. Chest 133 (2008) 454S-545S
6. Torbicki A., Perrier A., Konstantinides S., Agnelli G., Galié N., Pruszczyk P., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology. Eur Heart J 29 (2008) 2276-2315
7. Konstantinindes S., Geibel A., Heusel G., Heinrich F., Kasper W., and for the Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism. N Engl J Med 347 (2002) 1143-1150
8. Keyt B.A., Paoni N.F., Refino C.J., Berleau L., Nguyen H., Chow A., et al. A faster-acting and more form of tissue plasminogen activator. Proc Natl Acad Sci U S A 91 (1994) 3670-3674
9. ASSENT-II Investigators. Single-bolus Tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 354 (1999) 716-722
10. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of Tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358 (2001) 605-613
11. Sze D.Y., Carey M.B.L., and Razavi M.K. Treatment of massive pulmonary embolus with catheter-directed Tenecteplase. J Vasc Interv Radiol 12 (2001) 12
12. Caldicott D., Parasivam S., Harding J., Edwards N., and Bochner F. Tenecteplase for massive pulmonary embolus. Resuscitation 55 (2002) 211-213
13. Kline J., Hernanedz-Nino J., and Jones A.E. Tenecteplase to treat pulmonary embolism in the emergency department. J Thromb Thrombolysis 23 (2007) 101-105
14. Goldhaber S.Z., Haire W.D., Feldstein M.L., Miller M., Toltzis R., Smith J.L., et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341 (1993) 507-511
15. Goldhaber S.Z., Vaughan D.E., Markis J.E., Selwyn A.P., Meyerovitz M.F., Lo Scalzo J., et al. Acute pulmonary embolism treated with tissue plasminogen activator. Lancet 2 (1986) 886-889
16. Dalla-Volta S., Palla A., Santolicandro A., Giuntini C., Pengo V., Visioli O., et al. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2. JACC 20 (1992) 520-526
17. Meneveau N., Ming L.P., Séronde M.F., Mersin N., Schiele F., Caulfield F., et al. In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Eur Heart J 24 (2003) 1447-1454
18. Binder L., Pieske B., Olschewski M., Geibel A., Klostermann B., Reiner C., et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112 (2005) 1573-1579
19. Kucher N., Wallmann D., Carone A., Windecker S., Meier B., and Hess O.M. Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism. Eur Heart J 24 (2003) 1651-1656
20. Janin S., Meneveau N., Mahemuti A., Descotes-Genon V., Dutheil J., Chopard R., et al. Safety and efficacy of fondaparinux as an adjunctive treatment to thrombolysis in patients with high and intermediate risk pulmonary embolism. J Thromb Thrombolysis 28 (2009) 320-324
21. Konstantinides S. Acute pulmonary embolism. N Engl J Med 359 (2008) 2804-2813